Mike Leonard

1 week ago | news.bloomberglaw.com | Mike Leonard

COURT: Del. Ch.TRACK DOCKETS: Nos. 2025-0651 and 2025-0656 (Bloomberg Law subscription)Nielsen Holdings Ltd. affiliates launched a multi-pronged court bid to close the sale of a segment to Circana LLC, which is allegedly trying to renege over meddling by a former Nielsen affiliate. The media analytics giant is suing both Circana and Nielsen IQ, a consumer intelligence company—and direct competitor of Circana—that spun off in 2021.

1 week ago | news.bloomberglaw.com | Mike Leonard

persuaded Delaware’s top court Tuesday to overturn $199 million in damages stemming from its $13 billion acquisition ofThe state’s justices reversed a pair of rulings blaming the former TransCanada Corp. for driving down the transaction price with threats to damage Columbia’s market value by publicly bailing on deal talks. The lawsuit, filed in 2020, said the Calgary-based energy giant crossed the line by exploiting inside information gleaned from secret talks with a Columbia executive.

1 week ago | news.bloomberglaw.com | Mike Leonard |Jennifer Kay

Atlas Energy Solutions Inc.‘s founder and directors lost their bid Tuesday for an early win against allegations they shortchanged public investors when they reorganized the company in the months following its 2023 public listing. A Delaware Chancery Court judge let shareholder claims move forward over the reshuffling, which transformed the fracking services business from a traditional corporation into an Up-C, or publicly traded partnership. The decision by Vice Chancellor J.

2 weeks ago | news.bloomberglaw.com | Mike Leonard |Jef Feeley

Barry Diller’s IAC agreed to a $30 million settlement to resolve claims that investors were shortchanged in its spinoff of Match Group Inc., which operates dating apps including Tinder and Hinge. The case filed in Delaware Chancery Court, helped spark major changes to laws on dealmaking involving companies and controlling shareholders — changes catalyzed by Elon Musk’s decision to reincorporate his companies outside Delaware.

2 weeks ago | news.bloomberglaw.com | Mike Leonard

An AstraZeneca Plc affiliate suffered a greater than $180 million court loss Wednesday over its lackluster efforts to commercialize a drug connected to an acquisition priced at up to $1.2 billion. A Delaware judge ordered Alexion Pharmaceuticals Inc. to pay $181 million in damages, plus interest, to former investors in Syntimmune Inc., which it bought in a 2018 transaction that provided for payments of up to $800 million based on post-deal triggers.